Accès ouvert

Deduction of full factorial design of HPLC technique for the simultaneous analysis of meloxicam and esomeprazole in their laboratory prepared tablets

Article scientifique 2025 Anglais

Résumé

A reversed phase HPLC method with UV detection was designed for the first time for the simultaneous estimation of meloxicam and esomeprazole in their combined tablet dosage forms. Full factorial design was used for rapid optimization of the proposed method. Chromatographic separation was reached using isocratic elution on C18 column. The mobile phase was a mixture of methanol: acetonitrile: 0.05 M potassium dihydrogen phosphate buffer at pH 5, adjusted using phosphoric acid and/or NaOH when needed. The flow rate was 1 mL/min and the injection volume was 20 µL. The detection wavelength was 230 nm. The working ranges of the method were 5.0-100.0 and 10.0-100.0 µg/mL, LOD values were 0.8 and 1.8 µg/mL and LOQ values were 2.6 and 5.5 µg/mL for meloxicam and esomeprazole, respectively. The proposed method was successfully applied to their combined tablet dosage forms with acceptable % recoveries (100.4 - 100.7%) obtained. Four methods were used to evaluate the greenness of the proposed method, suggesting the acceptability of the greenness of the proposed method.

Citer ce document

Ramadan, H., Belal, F., Roshdy, A., Salim, M. (2025). Deduction of full factorial design of HPLC technique for the simultaneous analysis of meloxicam and esomeprazole in their laboratory prepared tablets. https://doi.org/10.1038/s41598-025-95706-3

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Statistiques

Consultations : 1

Téléchargements : 0